A Phase IIb trial of Lunacalcipol (CTA018).
Latest Information Update: 13 Feb 2017
At a glance
- Drugs Lunacalcipol (Primary)
- Indications Secondary hyperparathyroidism
- Focus Therapeutic Use
- 13 Feb 2017 New trial record
Latest Information Update: 13 Feb 2017